• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee
Which routine is right for you?See your routine

Research review

Saw palmetto benefits: what the research does and doesn't show

The largest, best-designed trials of saw palmetto — including a Cochrane review of 5,666 men — found it no better than placebo for prostate and urinary symptoms, even at triple the standard dose. Hair-loss evidence is smaller, weaker and mostly about a different combination product.

By Electric Tiger Editorial

The evidence doesn't support saw palmetto as a treatment for an enlarged prostate, urinary symptoms, or hair loss. The largest and best-designed trials — including a Cochrane review pooling 5,666 men — found it performed no better than placebo, even at triple the standard dose. The hair-loss evidence is smaller and weaker still, and mostly tested saw palmetto alongside another compound, not on its own.

What the evidence doesn't support

It doesn't support saw palmetto, at any dose sold on a label today, for benign prostatic hyperplasia (BPH), an enlarged prostate, lower urinary tract symptoms, or male-pattern (androgenetic) hair loss. It doesn't support using it to lower DHT, block the enzyme 5-alpha-reductase, or shrink the prostate in place of a doctor-directed treatment. It doesn't support any specific brand or product over another — none of the trials below tested a specific commercial product, and nothing here is a claim about any product.

What the trials found

The biggest body of evidence is on the prostate and urinary side, and it's consistently negative. A 2006 double-blind trial in the New England Journal of Medicine randomized 225 men over 49 with moderate-to-severe BPH symptoms to one year of saw palmetto extract at the standard dose (160 mg twice daily) or placebo, and found no significant difference in symptom scores, urine flow, prostate size, or PSA. A larger follow-up trial (the CAMUS study, 2011) went further: 369 men took saw palmetto starting at that same standard dose and escalating up to three times it — 960 mg a day — over 72 weeks, and still found no benefit over placebo on the main symptom score or on any of ten secondary measures, including sexual function and sleep quality. A 2012 Cochrane review then pooled 32 randomized trials across 5,666 men, trial lengths from 4 to 72 weeks, and reached the same conclusion at the largest scale yet: saw palmetto, even at double and triple the standard dose, did not improve symptom scores, urine flow, or prostate size compared with placebo.

A separate, more recent 2026 narrative review complicates that picture slightly. It found that saw palmetto extracts made by different methods — hexane, alcohol, and supercritical CO2 — are chemically distinct, and that most of the positive clinical evidence, including some trials reporting improvement in nighttime urination and peak urine flow, is specific to the hexane-extracted version. The review's authors argue that lumping every "saw palmetto extract" together, regardless of how it was made, may understate what one specific extract does and overstate what another does. That's a real, unresolved disagreement in the field — the Cochrane review above pooled trials using several extraction methods and found no effect; a narrative review focused on one extraction method reports a different picture. Neither settles which extract, if any, a given commercial capsule matches, since alcohol- and CO2-extracted products don't carry the same trial support either way.

The connection to hormones comes from a 2005 laboratory study, not a trial in people. Researchers exposed human prostate cancer cell lines to a specific hexanic extract and found it blocked 5-alpha-reductase, the enzyme that converts testosterone into DHT, without reducing the cells' PSA output the way synthetic 5-alpha-reductase inhibitor drugs do. That's a genuine finding about what happens to cells in a dish — it is not a measurement of DHT, testosterone, or any symptom in a person who swallows a capsule, and none of the placebo-controlled human trials above found the clinical result that mechanism might predict.

Hair-loss research is much smaller and weaker. A 2002 pilot trial gave a combination of saw palmetto extract and beta-sitosterol — not saw palmetto by itself — to 10 men with mild-to-moderate androgenetic alopecia, with 9 on placebo; investigators rated 6 of the 10 treated men improved at the final visit, but the published abstract doesn't report the placebo group's result, and the study used investigator judgment from photographs rather than an objective hair count.

Trial Population Dose Result
Bent 2006 (n=225) Men with moderate-severe BPH symptoms 320 mg/day, 1 year No difference vs. placebo
Barry/CAMUS 2011 (n=369) Men with LUTS 320 mg/day escalating to 960 mg/day, 72 weeks No difference vs. placebo at any dose
Tacklind/Cochrane 2012 (32 trials, n=5,666) Men with LUTS/BPH Varied, up to triple standard dose No difference vs. placebo, pooled
Prager 2002 pilot (n=19) Men with mild-moderate androgenetic alopecia Saw palmetto + beta-sitosterol combo 6/10 rated improved; no placebo result reported

Questions people ask

What is saw palmetto good for?

It's sold mostly for prostate, urinary and hair-related reasons, but the largest, best-designed trials found it no better than placebo for urinary symptoms, and the hair-loss evidence is small and weak. There's no trial showing a clear benefit for a general, healthy population using it for anything.

Is saw palmetto good for the prostate? Does it shrink the prostate?

The largest trials say no. A 2012 Cochrane review of 32 randomized trials in 5,666 men found no significant difference between saw palmetto and placebo in prostate size, urinary symptom scores, or urine flow rate — even at double and triple the standard dose. Two large individual trials (225 and 369 men) reached the same conclusion on their own.

Does saw palmetto block DHT?

One laboratory study found a specific extract blocked the enzyme that converts testosterone into DHT — but that was cells in a dish, not a measurement of DHT levels in a person. None of the placebo-controlled human trials above found the symptom improvement that mechanism would predict if it worked the same way in the body.

Does saw palmetto help with hair loss or growth?

The evidence is much thinner than for the prostate. A small pilot trial tested saw palmetto combined with another compound (not saw palmetto alone) and reported improvement in most treated men, but didn't report a comparable placebo result. No placebo-controlled trial of saw palmetto on its own has shown an effect on hair, so this is far from settled.

Does saw palmetto help with erectile function?

No trial we found tested saw palmetto for that directly. The one large trial that measured sexual function as a secondary outcome (the CAMUS study) found no difference between saw palmetto and placebo on that measure.

Does saw palmetto make you urinate more or less?

No. The CAMUS trial specifically measured nighttime urination (nocturia) and found no significant difference between saw palmetto and placebo, even at triple the standard dose.

Is saw palmetto good for women?

Very little research has included women. One placebo-controlled trial, reported at 90 and 180 days in 2025 and 2026, enrolled adults with self-perceived thinning hair (about half of them women) and found more hair with a 160 mg/day saw palmetto extract than with placebo. It is a single trial of one extract, not yet repeated, and it measured hair only. The prostate research summarized above was done in men. See saw palmetto for women and saw palmetto and hair for the details.

Is saw palmetto good for kidneys?

No trial we found tested saw palmetto for kidney health or kidney disease. That's not part of the research base described here.

When to talk to a doctor

Saw palmetto is not a treatment for benign prostatic hyperplasia, an enlarged prostate, urinary symptoms, or hair loss. Frequent, urgent, weak or painful urination, blood in the urine, or a rapidly enlarging prostate are reasons to see a doctor rather than try a supplement, since some of those symptoms can signal a condition a supplement search wouldn't catch. The same applies to sudden or patchy hair loss, which can have causes unrelated to androgenetic alopecia. If you're pregnant, nursing, or take prescription medication, talk to a doctor before adding saw palmetto — see saw palmetto and medications: what to check.

Related reading: what is saw palmetto, how much saw palmetto should you take a day, saw palmetto side effects, and who should not take saw palmetto.

Sources

  1. Serenoa repens for benign prostatic hyperplasia The Cochrane database of systematic reviews · 2012 · PMID 23235581A Cochrane review pooling 32 randomized trials in 5,666 men found saw palmetto, even at double and triple the standard dose, was no better than placebo for urinary symptom scores, urine flow, or prostate size.
  2. Saw palmetto for benign prostatic hyperplasia The New England journal of medicine · 2006 · PMID 16467543A one-year randomized trial in 225 men found the standard dose of saw palmetto extract (320 mg/day) performed no better than placebo on urinary symptom scores or urine flow.
  3. Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial JAMA · 2011 · PMID 21954478A 72-week randomized trial that escalated saw palmetto up to triple the standard dose (960 mg/day) in 369 men found it did not reduce urinary symptoms more than placebo at any dose tested.
  4. Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression International journal of cancer · 2005 · PMID 15543614A laboratory study found one specific saw palmetto extract blocked an enzyme that converts testosterone to DHT in cultured prostate cells, without lowering PSA production in those cells — a cell-culture finding, not proof it changes hormone levels in someone taking a capsule.
  5. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia Journal of alternative and complementary medicine (New York, N.Y.) · 2002 · PMID 12006122A small pilot trial of saw palmetto combined with beta-sitosterol — not saw palmetto alone — found investigators rated 6 of 10 men improved for hair loss; a small, preliminary result using a combination product, not a test of saw palmetto by itself.
  6. Pharmacology, efficacy and safety of different extracts of Serenoa repens in patients with lower urinary tract symptoms and benign prostatic hyperplasia: a narrative review Minerva urology and nephrology · 2026 · PMID 42023747A 2026 narrative review found that saw palmetto extracts vary chemically depending on how they're made (hexane, alcohol or CO2), and that most of the existing clinical-trial evidence applies to one specific extraction method rather than saw palmetto as a single, interchangeable ingredient.
  7. The Safety and Efficacy of a Proprietary Bioactive Fatty Acids Extract From Saw Palmetto (Serenoa repens) for Promoting Hair Growth and Reducing Hair Loss in Adults With Self-Perceived Thinning Hair: 90-Day Results Journal of cosmetic dermatology · 2025 · PMID 41319217A placebo-controlled trial of a specific 160 mg/day saw palmetto extract found significantly greater hair counts than placebo at 90 days in 60 adults, half of them women.
  8. The Safety and Efficacy of a Novel Saw Palmetto (Serenoa repens) Extract for Promoting Hair Growth in Adults With Self-Perceived Thinning Hair: 180-Day Results Journal of cosmetic dermatology · 2026 · PMID 41652806The 180-day results of the same trial found the treated group's advantage over placebo grew larger between Day 90 and Day 180, in both men and menopausal women.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.